Literature DB >> 17327554

Use of the femoral vein as insertion site for tunneled hemodialysis catheters.

Abigail Falk1.   

Abstract

PURPOSE: To determine the outcome of tunneled hemodialysis catheters inserted through the common femoral vein.
MATERIALS AND METHODS: From April 2000 to June 2003, 33 consecutive patients had 86 tunneled hemodialysis catheters inserted through the femoral vein. There were 14 male and 19 female patients with a mean age of 56 years. Seventeen patients had bilateral central venous and/or superior vena cava (SVC) occlusions, 12 patients had unilateral central venous occlusions and were to receive contralateral arteriovenous fistulas or arteriovenous polytetrafluoroethylene grafts, and 4 patients received femoral catheters for other reasons. The technical success, complications, and clinical outcomes of these procedures were retrospectively evaluated.
RESULTS: All procedures were technically successful. Fifty-seven catheters were inserted into the right femoral vein and 29 into the left femoral vein. This included 25 catheter exchanges in 13 patients. Two patients developed thigh hematomas. Follow-up data were available for 68 catheters; mean follow-up period was 51 days with a total of 3,484 catheter days. The catheter-related infection rate was 6.3 per 1,000 catheter days; 22 catheters were removed for infection. Eighteen catheters were removed because of poor blood flows (<200 mL/min). Thirteen catheters were removed because they had become retracted. Primary catheter patency was 44% at 1 month.
CONCLUSIONS: The femoral vein provides an alternative access site for insertion of tunneled hemodialysis catheters when conventional sites are not available. However, tunneled femoral hemodialysis catheters have low primary patency rates and significant complications. Catheter retraction is a unique and common problem.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17327554     DOI: 10.1016/j.jvir.2006.12.001

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


  8 in total

Review 1.  Lower Extremity Permanent Dialysis Vascular Access.

Authors:  Vishal B Parekh; Vandana D Niyyar; Tushar J Vachharajani
Journal:  Clin J Am Soc Nephrol       Date:  2016-05-27       Impact factor: 8.237

2.  Thigh grafts contribute significantly to patients' time on dialysis.

Authors:  Sunanda J Ram; Bharat A Sachdeva; Gloria C Caldito; Gazi B Zibari; Kenneth D Abreo
Journal:  Clin J Am Soc Nephrol       Date:  2010-04-22       Impact factor: 8.237

Review 3.  Vascular Access for Placement of Tunneled Dialysis Catheters for Hemodialysis: A Systematic Approach and Clinical Practice Algorithm.

Authors:  Keith Pereira; Adam Osiason; Jason Salsamendi
Journal:  J Clin Imaging Sci       Date:  2015-05-29

4.  Practical Aspects of Nontunneled and Tunneled Hemodialysis Catheters.

Authors:  Edward Clark; Joanne Kappel; Jennifer MacRae; Christine Dipchand; Swapnil Hiremath; Mercedeh Kiaii; Charmaine Lok; Louise Moist; Matthew Oliver; Lisa M Miller
Journal:  Can J Kidney Health Dis       Date:  2016-09-27

5.  Arteriovenous Access: Infection, Neuropathy, and Other Complications.

Authors:  Jennifer M MacRae; Christine Dipchand; Matthew Oliver; Louise Moist; Serdar Yilmaz; Charmaine Lok; Kelvin Leung; Edward Clark; Swapnil Hiremath; Joanne Kappel; Mercedeh Kiaii; Rick Luscombe; Lisa M Miller
Journal:  Can J Kidney Health Dis       Date:  2016-09-27

Review 6.  Central Venous Catheters for Hemodialysis-the Myth and the Evidence.

Authors:  Mohammad Ahsan Sohail; Tushar J Vachharajani; Evamaria Anvari
Journal:  Kidney Int Rep       Date:  2021-10-11

7.  The Patency Rate of the Primary and Exchanged Femoral Haemodialysis Catheters.

Authors:  Roozbeh Cheraghali; Pezhman Farshidmehr
Journal:  Malays J Med Sci       Date:  2021-08-26

8.  Tunneled Femoral Vein Catheterization for Long-term Hemodialysis - Experience from a Tertiary Care Center.

Authors:  Jasmine Sethi; Mragank Gaur; Manish Rathi; Harbir S Kohli
Journal:  Indian J Nephrol       Date:  2022-05-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.